Nu Skin Enterprises (NYSE:NUS - Get Free Report) is projected to post its Q2 2025 quarterly earnings results after the market closes on Thursday, August 7th. Analysts expect Nu Skin Enterprises to post earnings of $0.25 per share for the quarter. Nu Skin Enterprises has set its Q2 2025 guidance at 0.200-0.300 EPS and its FY 2025 guidance at 0.900-1.300 EPS.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. Nu Skin Enterprises had a positive return on equity of 6.99% and a negative net margin of 2.30%. The firm had revenue of $364.49 million during the quarter, compared to the consensus estimate of $352.06 million. On average, analysts expect Nu Skin Enterprises to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Nu Skin Enterprises Price Performance
Shares of NYSE NUS traded up $0.12 during mid-day trading on Monday, reaching $8.32. The company had a trading volume of 125,377 shares, compared to its average volume of 647,699. The firm has a market cap of $411.09 million, a price-to-earnings ratio of -10.41 and a beta of 0.91. The business's 50-day simple moving average is $8.33 and its 200 day simple moving average is $7.43. Nu Skin Enterprises has a one year low of $5.32 and a one year high of $10.88. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.29 and a current ratio of 2.02.
Nu Skin Enterprises Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th were issued a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Friday, May 30th. Nu Skin Enterprises's dividend payout ratio (DPR) is currently -30.00%.
Insider Transactions at Nu Skin Enterprises
In related news, Director Edwina D. Woodbury sold 4,532 shares of the company's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $8.44, for a total transaction of $38,250.08. Following the completion of the transaction, the director directly owned 42,947 shares in the company, valued at $362,472.68. This represents a 9.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Steven Keith Hatchett bought 6,500 shares of the firm's stock in a transaction on Wednesday, May 28th. The shares were bought at an average cost of $7.54 per share, for a total transaction of $49,010.00. Following the purchase, the insider owned 162,065 shares of the company's stock, valued at approximately $1,221,970.10. The trade was a 4.18% increase in their position. The disclosure for this purchase can be found here. Insiders own 2.00% of the company's stock.
Institutional Investors Weigh In On Nu Skin Enterprises
Hedge funds and other institutional investors have recently bought and sold shares of the company. Amundi boosted its holdings in Nu Skin Enterprises by 18.8% in the first quarter. Amundi now owns 18,564 shares of the company's stock valued at $127,000 after acquiring an additional 2,941 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Nu Skin Enterprises during the first quarter worth $162,000. AQR Capital Management LLC lifted its holdings in Nu Skin Enterprises by 64.6% in the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company's stock valued at $2,530,000 after buying an additional 137,475 shares during the period. Finally, Goldman Sachs Group Inc. boosted its position in Nu Skin Enterprises by 7.2% during the first quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company's stock valued at $9,582,000 after acquiring an additional 88,088 shares during the last quarter. Institutional investors own 82.84% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, May 12th.
Get Our Latest Research Report on Nu Skin Enterprises
About Nu Skin Enterprises
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.